INBX - Inhibrx Biosciences, Inc.

QQQ $ 475.72 $ 1.16 (0.24 %)

DIA $ 418.16 $ 1.26 (0.3 %)

SPY $ 565.14 $ 1.28 (0.23 %)

TLT $ 99.74 $ -0.58 (-0.58 %)

GLD $ 236.81 $ -1.38 (-0.58 %)

Previous Close

$ 17.22

Open

$ 16.98

Bid

$ 16.95 x 150

Ask

-- x --

Day's Range

$ 16.97 - $ 17.47

52 Week Range

$ 10.80 - $ 18.95

Volume

83,776

Average Volume

Market Cap

249.28M

Beta (5Y Monthly)

$ -1.84

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type	Report Link
1	08-13-2024	06-30-2024	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

around-2m-bet-on-franklin-resources-check-out-these-4-stocks-executives-are-buying

Around $2M Bet On Franklin Resources? Chec...
09/03/2024 12:28:49

over-7m-bet-on-this-health-care-stock-check-out-these-3-stocks-executives-are-buying

Over $7M Bet On This Health Care Stock? Ch...
08/27/2024 11:10:28

Inhibrx Biosciences Q2 EPS $125.48, Sales ...
08/14/2024 07:24:14

Inhibrx Biosciences (NASDAQ:INBX) reported quarterly earnings of $125.48 per share. This is a 3011.37 percent increase over los...

JMP Securities Initiates Coverage On Inhib...
07/23/2024 10:32:30

JMP Securities analyst Reni Benjamin initiates coverage on Inhibrx Biosciences (NASDAQ:INBX) with a Market Perform rating.

Inhibrx Biosciences 13G Filing Shows Vikin...
06/07/2024 20:29:47

– SEC Filing

top-4-health-care-stocks-that-are-preparing-to-pump-this-month

Top 4 Health Care Stocks That Are Preparin...
06/05/2024 11:46:52

Trading Halt: Halt status updated at 8:40:...
05/31/2024 12:40:03

Inhibrx Approve Sale Of INBRX-101 To Sanof...
05/24/2024 20:04:05

Inhibrx Q4 2023 GAAP EPS $(1.73) Misses $(...
02/28/2024 14:21:21

Inhibrx (NASDAQ:INBX) reported quarterly losses of $(1.73) per share which missed the analyst consensus estimate of $(1.04) by ...

french-drugmaker-sanofi-agrees-to-buy-inhibrxs-candidate-for-rare-genetic-indication-for-about-22b

French Drugmaker Sanofi Agrees To Buy Inhi...
01/23/2024 13:00:55

Sanofi's strategic acquisition of Inhibrx's INBRX-101, a alpha-1 antitrypsin therapy in a registrational trial. Learn a...

olympic-sponsor-sanofi-makes-major-play-in-rare-disease-arena-22-billion-acquisition-of-inhibrx-project

Olympic Sponsor Sanofi Makes Major Play In...
01/23/2024 12:46:00

Following the acquisition, New Inhibrx will continue to operate under the "Inhibrx" name, with Mark Lappe as Chairman a...

JMP Securities Downgrades Inhibrx to Marke...
01/23/2024 09:34:28

JMP Securities analyst Reni Benjamin downgrades Inhibrx (NASDAQ:INBX) from Market Outperform to Market Perform.

Inhibrx Sells INBRX-101 To Sanofi For Up T...
01/23/2024 06:09:08

Inhibrx, Inc. shareholders will receive per share consideration of $30 per share in cash, a CVR equal to $5, plus 0.25 shares i...

JMP Securities Reiterates Market Outperfor...
11/20/2023 14:19:19

JMP Securities analyst Reni Benjamin reiterates Inhibrx (NASDAQ:INBX) with a Market Outperform and maintains $27 price target.

Watching Axos Financial; The Bear Cave New...
11/16/2023 15:34:17

https://thebearcave.substack.com/p/problems-at-axos-financial-ax?utm_campaign

Inhibrx Q3 EPS $(1.10)
11/09/2023 22:11:58

Inhibrx Announces Preliminary Data From Th...
11/02/2023 13:20:33

Inhibrx, Inc. (NASDAQ:INBX), a clinical-stage biopharmaceutical company dedicated to the development of therapeutics for oncolo...

Inhibrx Announces Chiesi Farmaceutici S.p....
09/19/2023 20:01:17

$1.5M Bet On Domo? Check Out These 3 Stock...
08/31/2023 11:58:22

Although U.S. stocks closed higher on Wednesday, there were a few notable insider trades.

Why NIO Are Trading Lower By Over 7%? Here...
08/29/2023 16:51:54

Gainers Axcella Health Inc. (NASDAQ: AXLA) shares climbed 196% to $0.3335 after the company announced it was granted a pate...